(CIDRAP News) – As researchers continue to sort out safety issues surrounding the monovalent vaccine used during the 2009 H1N1 flu pandemic, two new reports focusing mainly on an adjuvanted version suggest that immunization was safe for babies born to vaccinated pregnant women and that it was linked to a small but significant risk of Guillain-Barre syndrome (GBS) in some patients.
Antiviral-resistant H1N1 virus in Australia didn't spread farAn oseltamivir-resistant 2009 H1N1 virus that spread in one Australian community in 2011 apparently did not escape to a nearby large city, according to a report published in Eurosurveillance yesterday. Researchers previously reported the community spread of a resistant 2009 H1N1 virus in the Newcastle, Australia, area from June through August of 2011, the report notes.
(CIDRAP News) – Working with admittedly sparse data, a research team led by the US Centers for Disease Control and Prevention (CDC) has estimated the global death toll from the 2009 H1N1 influenza pandemic at more than 284,000, about 15 times the number of laboratory-confirmed cases.
(CIDRAP News) – During the 2009 influenza pandemic, clinicians were frustrated by the lack of useful diagnostic tests, the government had no national system for monitoring stress on healthcare facilities, and there was some duplication in federal media campaigns.
(CIDRAP News) – Australia's CSL Biotherapies said today that viral components of its Fluvax seasonal flu vaccine led to the unexpected rise in febrile seizures in young Australian children during the 2010 flu season.
(CIDRAP News) – Clinicians are heeding antiviral prescribing guidance changes made over the past decade because of antiviral resistance and a greater focus on protecting high-risk patients, particularly during the 2009 H1N1 pandemic, researchers reported today.
(CIDRAP News) – Phone-based flu lines that operated during the 2009 H1N1 pandemic increased public flu knowledge, may have prevented unnecessary 911 calls and visits to health facilities, and eased access to antivirals when appropriate, a recent report found.